Brazilian Mushroom with Reishi
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Agaricus blazei Source : En entier Extract : Matériel brut sec Extraction ratio : 1.001:1 Dry plant equivalent : 1,001 milligramme | 1 millilitre | Not calculated |
| Ganoderma lucidum Source : En entier Extract : Matériel brut sec Extraction ratio : 1.001:1 Dry plant equivalent : 1,001 milligramme | 1 millilitre | Not calculated |
Non-medicinal ingredients
Eau purifiée, Ethanol, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Droppers | 2 Tous les jours |
Uses authorised in Canada
Source of antioxidants. Source of fungal polysaccharides with immunomodulating properties. Reishi is used in Herbal Medicine as a liver tonic and an adaptogen to help increase energy resistance to stress (e.g. in case of mental and physical fatigue related to stress). Reishi is used in Traditional Chinese Medicine (TCM) to dispel phlegm, stop coughing and arrest wheezing. Reishi is used in Traditional Chinese Medicine (TCM) to nourish the heart and strengthen the body, qi and blood, to treat Heart and Spleen deficiencies that manifest in insomnia, forgetfulness, fatigue, listlessness and poor appetite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
For use beyond 3 months: Dizziness, irritated skin, nausea and diarrhea have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. If you suffer from an immune system disorder or if you are taking immunosuppressants, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner immediately if you develop any of the following symptoms: nausea, vomiting, loss of appetite combined with itching, yellowing of the skin or eyes, dark urine.
Product record
- Licence holder
- Dr. Ma's Laboratories Inc.
- NPN or DIN-HM
- 80092947
- Status
- Active licence
- Licence date
- 20 June 2019
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80092947
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Brazilian Mushroom with Reishi (Dr. Ma's Laboratories Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80092947-brazilian-mushroom-with-reishi, updated 20 June 2019.